METHODS: Between January 2019 and January 2020, 118 consecutive patients with HL treated with TS (TS group, n = 57) or LH (LH group, n = 61) were analyzed in this study. Perioperative and long-term outcomes, including operative time, intraoperative blood loss, blood transfusion, postoperative bowel function recovery time, postoperative hospital stay, complication rate, stone removal rate, and stone recurrence rate, were compared and analyzed between the two groups.
RESULTS: Compared with the LH group, the TS group had significantly lower intraoperative blood loss and transfusions, significantly shorter operative time and hospital stay, and fewer complications (P < 0.05 for all). There was no significant difference in the final stone removal rate, stone recurrence rate and postoperative bowel function recovery time (P > 0.05 for all).
CONCLUSIONS: TS is a safe and effective treatment for HL and is superior to LH in terms of overall treatment outcome and complications.
方法:在2019年1月至2020年1月之间,118例连续接受TS治疗的HL患者(TS组,n=57)或LH(LH组,n=61)在这项研究中进行了分析。围手术期和长期结果,包括手术时间,术中失血,输血,术后肠功能恢复时间,术后住院时间,并发症发生率,结石去除率,结石复发率,进行对比分析。
结果:与LH组相比,TS组的术中出血量和输血量明显减少,手术时间和住院时间明显缩短,并发症少(均P<0.05)。最终结石去除率无显著差异,结石复发率及术后肠功能恢复时间(均P>0.05)。
结论:TS是HL安全有效的治疗方法,在总体治疗结果和并发症方面优于LH。